Adriana Heguy
Adriana Heguy
NYU School of Medicine
Verified email at
Cited by
Cited by
Integrative genomic profiling of human prostate cancer
BS Taylor, N Schultz, H Hieronymus, A Gopalan, Y Xiao, BS Carver, ...
Cancer cell 18 (1), 11-22, 2010
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia
JP Patel, M Gönen, ME Figueroa, H Fernandez, Z Sun, J Racevskis, ...
New England Journal of Medicine 366 (12), 1079-1089, 2012
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
S Turcan, D Rohle, A Goenka, LA Walsh, F Fang, E Yilmaz, C Campos, ...
Nature 483 (7390), 479-483, 2012
Mutations in GNA11 in Uveal Melanoma
CD Van Raamsdonk, KG Griewank, MB Crosby, MC Garrido, S Vemula, ...
New England Journal of Medicine 363 (23), 2191-2199, 2010
Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis
L Busque, JP Patel, ME Figueroa, A Vasanthakumar, S Provost, ...
Nature genetics 44 (11), 1179-1181, 2012
Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
O Abdel-Wahab, A Mullally, C Hedvat, G Garcia-Manero, J Patel, ...
Blood, The Journal of the American Society of Hematology 114 (1), 144-147, 2009
The bone marrow microenvironment at single-cell resolution
AN Tikhonova, I Dolgalev, H Hu, KK Sivaraj, E Hoxha, ...
Nature 569 (7755), 222-228, 2019
Radiotherapy induces responses of lung cancer to CTLA-4 blockade
SC Formenti, NP Rudqvist, E Golden, B Cooper, E Wennerberg, ...
Nature medicine 24 (12), 1845-1851, 2018
Genome sequencing identifies a basis for everolimus sensitivity
G Iyer, AJ Hanrahan, MI Milowsky, H Al-Ahmadie, SN Scott, ...
Science 338 (6104), 221-221, 2012
Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1
JC Ricarte-Filho, M Ryder, DA Chitale, M Rivera, A Heguy, M Ladanyi, ...
Cancer research 69 (11), 4885-4893, 2009
The integrated landscape of driver genomic alterations in glioblastoma
V Frattini, V Trifonov, JM Chan, A Castano, M Lia, F Abate, ST Keir, AX Ji, ...
Nature genetics 45 (10), 1141-1149, 2013
Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
R Romero, VI Sayin, SM Davidson, MR Bauer, SX Singh, SE LeBoeuf, ...
Nature medicine 23 (11), 1362-1368, 2017
Association of age at diagnosis and genetic mutations in patients with neuroblastoma
NKV Cheung, J Zhang, C Lu, M Parker, A Bahrami, SK Tickoo, A Heguy, ...
Jama 307 (10), 1062-1071, 2012
The mutational landscape of adenoid cystic carcinoma
AS Ho, K Kannan, DM Roy, LGT Morris, I Ganly, N Katabi, D Ramaswami, ...
Nature genetics 45 (7), 791-798, 2013
Diverse and targetable kinase alterations drive histiocytic neoplasms
EL Diamond, BH Durham, J Haroche, Z Yao, J Ma, SA Parikh, Z Wang, ...
Cancer discovery 6 (2), 154-165, 2016
PIK3CA mutation associates with improved outcome in breast cancer
K Kalinsky, LM Jacks, A Heguy, S Patil, M Drobnjak, UK Bhanot, ...
Clinical cancer research 15 (16), 5049-5059, 2009
Somatic mutations of the Parkinson's disease–associated gene PARK2 in glioblastoma and other human malignancies
S Veeriah, BS Taylor, S Meng, F Fang, E Yilmaz, I Vivanco, ...
Nature genetics 42 (1), 77-82, 2010
Identification and purification of a human lymphoid-specific octamer-binding protein (OTF-2) that activates transcription of an immunoglobulin promoter in vitro
C Scheidereit, A Heguy, RG Roeder
Cell 51 (5), 783-793, 1987
A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms
O Kilpivaara, S Mukherjee, AM Schram, M Wadleigh, A Mullally, BL Ebert, ...
Nature genetics 41 (4), 455-459, 2009
Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias
O Abdel-Wahab, T Manshouri, J Patel, K Harris, JJ Yao, C Hedvat, ...
Cancer research 70 (2), 447-452, 2010
The system can't perform the operation now. Try again later.
Articles 1–20